‘Relentless’ 340B Policy Leader Among Coming Congressional Retirements

Rep. Abigail Spanberger (D-Va.), who has been a vocal advocate of provider access to the 340B program, is one of 38 members of Congress to announce their planned departures this year.
A congresswoman who has led legislative initiatives to bolster provider access to the 340B program was among 12 members of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Senate Drug Shortage Hearing to Include 340B-Researcher Witnesses

Sen. Ron Wyden (D-Ore.), chairman of the Senate Finance Committee, announced a Dec. 5 hearing on prescription drug shortages that will include testimony from two witnesses who have published research on the 340B program.
A Senate Finance Committee Dec. 5 hearing on prescription drug shortages will include testimony from two witnesses who have written [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Unlocking the TRUE POTENTIAL of 340B

SPONSORED CONTENT

Primary care organizations often view themselves as a “Medical Home” for their patients, focusing on resolving patient health problems through their medical services. However, a significant challenge for providers lies in the inability to monitor and influence a patient’s behavior in the time between medical visits. Surprisingly, pharmacy professional services, designed to address this need, remain underutilized and are rarely integrated into medical workflows.

Understanding Pharmacy Professional Services

Pharmacy professional services can be defined differently by practice setting, but they encompass a range of activities performed by pharmacy resources to improve the outcomes of medication therapy. Essentially, these services eliminate barriers to drug therapy failure which can be categorized into three main buckets:

  1. Poor access or affordability
  2. Educational gaps
  3. Clinical effectiveness and side effects

Despite the pressing need for addressing these barriers, the current primary care infrastructure does not fully integrate these aspects into a multidisciplinary approach. However, this is

Read More »

N.Y. State, Health Centers Seek Brief Pause in Medicaid Drug Benefit Lawsuit

The parties involved in a legal challenge over certain Medicaid managed care drug benefits have jointly asked for a pause in proceedings.
Both sides in a lawsuit over New York state’s transfer of Medicaid managed care drug benefits to Medicaid fee for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Why the Genesis 340B Patient Definition Court Decision Could Resolve the Contract Pharmacy Impasse

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
In what legal experts describe as a landmark decision, the U.S. District Court for the District of South Carolina ruled [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Massachusetts Senate Passes 340B Contract Pharmacy Protections for Certain 340B Grantees, Hospitals

Sen. Pavel Payano's (D) amendment to protect 340B grantees and some hospitals from contract pharmacy restrictions is part of a healthcare bill that recently passed the Massachusetts state senate.
Massachusetts state senators this month unanimously passed a healthcare bill that would protect 340B grantees and certain safety net hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Provides Benefits, Needs Reform, Says Literature Review

A JAMA Health Network literature review found that the 340B program provides a range of benefits but needs reforms.
The 340B program has provided a range of benefits but also needs reforms, according to a recent review of published [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B’s Footprint in Medicare Part D Is Growing, Study Says

A JAMA Health Forum study co- authored by Sean Dickson found the 340B program's footprint in Medicare Part D is increasing.
340B covered entities captured nearly half (49.9%) of their 340B-eligible prescriptions billed to Medicare Part D in 2020, up from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sen. Cassidy Mum on Next Steps for 340B Provider Probes

Sen. Bill Cassidy (R-La.) expanded his 340B inquiry to CVS Health and Walgreens amid growing scrutiny over 340B contract pharmacies and TPAs.
The influential senator who launched an inquiry into how two community health centers and two 340B hospitals use 340B savings [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report